Source: Atherosclerosis. Unidades: FM, FCF
Subjects: PLASMA, HIPERCOLESTEROLEMIA (GENÉTICA;METABOLISMO), DOENÇAS HEREDITÁRIAS, LIPOPROTEÍNAS LDL, EMULSÕES (FORMAS FARMACÊUTICAS)
ABNT
CARNEIRO, Marcia M. et al. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions. Atherosclerosis, v. 221, n. 1, p. 268-274, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2011.12.033. Acesso em: 18 ago. 2024.APA
Carneiro, M. M., Miname, M. H., Gagliardi, A. C., Pereira, C., Pereira, A. C., Krieger, J. E., et al. (2012). The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions. Atherosclerosis, 221( 1), 268-274. doi:10.1016/j.atherosclerosis.2011.12.033NLM
Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions [Internet]. Atherosclerosis. 2012 ; 221( 1): 268-274.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.12.033Vancouver
Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions [Internet]. Atherosclerosis. 2012 ; 221( 1): 268-274.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.12.033